GULIYEV, Murad et al. Evaluating the Prognostic Role of Pan-Immune-Inflammation Value in Patients with Advanced Non-Small Cell Lung Cancer Treated with Nivolumab. Cerrahpaşa Medical Journal, [S. l.], v. 49, n. 1, p. 1–9, 2025. DOI: 10.5152/cjm.2025.25038. Disponível em: https://cerrahpasamedj.org/index.php/pub/article/view/965. Acesso em: 18 dec. 2025.